Fujian Medical University Union Hospital
🇨🇳China
Tumor Regression Grade As Predictor of Adjuvant Therapy
- First Posted Date
- 2024-11-28
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06710665
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Insomnia with Subjective Cognitive Decline
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-11-28
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT06710652
Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 76
- Registration Number
- NCT06694597
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-11-07
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06677931
- Locations
- 🇨🇳
Affiliated Union Hospital of Fujian Medical University, Fuzhou, Fujian, China
🇨🇳Chenxiaosong, Fujian, fuzhou, China
A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06630871
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT06601309
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-13
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 51
- Registration Number
- NCT06593899
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 722
- Registration Number
- NCT06559696
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT06510660
- Locations
- 🇨🇳
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for Anesthesia
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-12
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Fujian Medical University Union Hospital
- Target Recruit Count
- 496
- Registration Number
- NCT06497660
© Copyright 2024. All Rights Reserved by MedPath